Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the C-Reactive Protein Testing Market from 2024 to 2025?

Over the past few years, the size of the c-reactive protein testing market has seen consistent growth. The market is projected to expand from $3.45 billion in 2024 to $3.55 billion in 2025, with a compound annual growth rate (CAGR) of 2.9%. This upward trend during the historical period can be linked to factors such as the rising occurrence of inflammatory diseases, the assessment of cardiovascular risk, an aging population, enhanced healthcare infrastructure, and health screening initiatives.

What Is the Projected Market Size of the C-Reactive Protein Testing Market?

Expectations are high for the c-reactive protein testing market, which is anticipated to experience robust growth in the coming years. By 2029, the market is projected to reach $4.35 billion, with a compound annual growth rate (CAGR) of 5.2%. Contributing factors to this anticipated growth during the forecast period include an increase in obesity rates, advancements in personalized medicine and biomarkers, developments in telehealth and remote monitoring, precocious disease detection, and lifestyle-related inflammation. Key trends expected during the forecast period involve advancements in diagnostic testing, the rise of wearable health technology, entrance of technological solutions, strategic collaborations, and the roll-out of industry 4.0.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

Who are the Major Competitors in the C-Reactive Protein Testing Market Outlook?

Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

What Is Fueling Growth in the C-Reactive Protein Testing Market?

The rise in cardiovascular disease (CVD) instances is projected to spur the expansion of the c-reactive protein testing market. CVDs encompass conditions like diseased vessels, heart structure issues, and blood clots. The precise root cause of CVDs remains ambiguous, but several elements could heighten the probability of their onset. One such element is behavioral risks such as improper diet, inadequate physical exercise, smoking, and drinking, all of which contribute to fatty deposit build-up within the arteries (atherosclerosis), hence amplifying blood clot risks. These behavioral habits trigger an escalation in blood pressure, glucose, blood lipids, weight, and obesity. The amplified number of CVD occurrences underlines the requirement for c-reactive protein testing to assess or anticipate the chance of experiencing heart-related problems, much like cholesterol levels. For example, in December 2023, the Institute for Health Metrics and Evaluation reported reaching 19.8 million worldwide deaths from CVDs in 2022, with ischemic heart disease accounting for 108.8 deaths per 100,000 individuals. High systolic blood pressure was the largest contributor to disability-adjusted life years (DALYs) related to CVD, whereas dietary risks and air pollution were significant behavioral and environmental contributors to this global issue.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6719&type=smp

Which C-Reactive Protein Testing Market Segments Are Growing the Fastest?

The c-reactive protein testing market covered in this report is segmented –

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays

2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications

3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Subsegments:

1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA

2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems

3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

Which Industry Trends Are Shaping the Future of the C-Reactive Protein Testing Market?

The surge in technology advancements in measuring tools is a notable trend unfolding in the c-reactive protein testing market. Leading firms in the sector are centering their efforts on offering state-of-the-art solutions with a view to cement their standing in the market. These organizations are incorporating avant-garde c-reactive testing techniques into their testing procedures and innovative solutions that promise perks like exceptional efficiency and assorted applications. To cite an example, in February 2022, Aidian, a company hailing from Finland that specializes in diagnostic tests and testing solutions, launched the QuikRead go wrCRP & wrCRP+Hb kits. This kit ensures the consistent delivery of dual results – a broad spectrum of CRP and Hb, obtained from a singular sample through one analysis. This broad spectrum CRP test enables the assessment of conditions such as neonatal sepsis, an estimation of the severity of diseases including COPD (chronic obstructive pulmonary disease), and provides assistance in carrying out cardiovascular risk assessments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Which Countries Are Leading the C-Reactive Protein Testing Market?

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6719

This Report Delivers Insight On:

1. How big is the c-reactive protein testing market, and how is it changing globally?

2. Who are the major companies in the c-reactive protein testing market, and how are they performing?

3. What are the key opportunities and risks in the c-reactive protein testing market right now?

4. Which products or customer segments are growing the most in the c-reactive protein testing market?

5. What factors are helping or slowing down the growth of the c-reactive protein testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model